288 related articles for article (PubMed ID: 36522388)
1. Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Jansen D; De Coninck L; Close L; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; Matthijnssens J; Oteo JA
Sci Rep; 2022 Dec; 12(1):21658. PubMed ID: 36522388
[TBL] [Abstract][Full Text] [Related]
2. Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Infect Dis Ther; 2022 Aug; 11(4):1541-1557. PubMed ID: 35618952
[TBL] [Abstract][Full Text] [Related]
3. Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome.
Villoslada-Blanco P; Pérez-Matute P; Recio-Fernández E; Íñiguez M; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Sci Rep; 2023 Aug; 13(1):14327. PubMed ID: 37653055
[TBL] [Abstract][Full Text] [Related]
4. Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs.
Smith SJ; Zhao XZ; Passos DO; Lyumkis D; Burke TR; Hughes SH
Viruses; 2021 Jan; 13(2):. PubMed ID: 33572956
[TBL] [Abstract][Full Text] [Related]
5. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection.
Park TE; Mohamed A; Kalabalik J; Sharma R
Expert Rev Anti Infect Ther; 2015; 13(10):1195-212. PubMed ID: 26293294
[TBL] [Abstract][Full Text] [Related]
6. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.
Zhao AV; Crutchley RD; Guduru RC; Ton K; Lam T; Min AC
Retrovirology; 2022 Oct; 19(1):22. PubMed ID: 36273165
[TBL] [Abstract][Full Text] [Related]
7. New designs for HIV-1 integrase inhibitors: a patent review (2018-present).
Taoda Y; Sugiyama S; Seki T
Expert Opin Ther Pat; 2023 Jan; 33(1):51-66. PubMed ID: 36750766
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of resistance to integrase strand-transfer inhibitors (INSTIs) among untreated HIV-1 infected patients in Morocco.
Alaoui N; El Alaoui MA; Touil N; El Annaz H; Melloul M; Tagajdid R; Hjira N; Boui M; El Fahime EM; Mrani S
BMC Res Notes; 2018 Jun; 11(1):369. PubMed ID: 29884219
[TBL] [Abstract][Full Text] [Related]
9. Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
Acharya A; Tagny CT; Mbanya D; Fonsah JY; Nchindap E; Kenmogne L; Jihyun M; Njamnshi AK; Kanmogne GD
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106437
[No Abstract] [Full Text] [Related]
10. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants.
Smith SJ; Zhao XZ; Passos DO; Lyumkis D; Burke TR; Hughes SH
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601157
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
[TBL] [Abstract][Full Text] [Related]
13. Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study.
Cheung PK; Shahid A; Dong W; Lepik KJ; Montaner JSG; Brockman MA; Brumme ZL; Brumme CJ
J Antimicrob Chemother; 2022 Mar; 77(4):979-988. PubMed ID: 35061879
[TBL] [Abstract][Full Text] [Related]
14. A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
Le Hingrat Q; Collin G; Lê M; Peytavin G; Visseaux B; Bertine M; Tubiana R; Karmochkine M; Valin N; Collin F; Lemaignen A; Bernard L; Damond F; Matheron S; Descamps D; Charpentier C;
Clin Infect Dis; 2019 Aug; 69(4):657-667. PubMed ID: 30383215
[TBL] [Abstract][Full Text] [Related]
15. Gut virome dysbiosis following focal cerebral ischemia in mice.
Chelluboina B; Kieft K; Breister A; Anantharaman K; Vemuganti R
J Cereb Blood Flow Metab; 2022 Sep; 42(9):1597-1602. PubMed ID: 35702025
[TBL] [Abstract][Full Text] [Related]
16. The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients.
Quiros-Roldan E; Castelli F; Bonito A; Vezzoli M; Calza S; Biasiotto G; Zanella I;
Cytokine; 2020 Feb; 126():154884. PubMed ID: 31670006
[TBL] [Abstract][Full Text] [Related]
17. Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an
Ha CHX; Lee NK; Rahman T; Hwang SS; Yam WK; Chee XW
J Biomol Struct Dyn; 2023 Apr; 41(6):2146-2159. PubMed ID: 35067186
[TBL] [Abstract][Full Text] [Related]
18. Community Types of the Human Gut Virome are Associated with Endoscopic Outcome in Ulcerative Colitis.
Jansen D; Falony G; Vieira-Silva S; Simsek C; Marcelis T; Caenepeel C; Machiels K; Raes J; Vermeire S; Matthijnssens J
J Crohns Colitis; 2023 Oct; 17(9):1504-1513. PubMed ID: 37052201
[TBL] [Abstract][Full Text] [Related]
19. The gut virome: A new microbiome component in health and disease.
Cao Z; Sugimura N; Burgermeister E; Ebert MP; Zuo T; Lan P
EBioMedicine; 2022 Jul; 81():104113. PubMed ID: 35753153
[TBL] [Abstract][Full Text] [Related]
20. Impact of HIV-1 Integrase L74F and V75I Mutations in a Clinical Isolate on Resistance to Second-Generation Integrase Strand Transfer Inhibitors.
Hachiya A; Kirby KA; Ido Y; Shigemi U; Matsuda M; Okazaki R; Imamura J; Sarafianos SG; Yokomaku Y; Iwatani Y
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
